Articles related to Pharmacy (Clinical/Hospital)

A consumer overview describes metformin’s potential roles in weight management, ovarian syndrome symptoms, and cardiovascular outcomes, but the reported findings involve different populations and do not establish equivalent benefits across these uses.

Accreditors described new programs for artificial intelligence and immunoglobulin services, revised oncology dispensing materials, and more frequent DMEPOS surveys, with differing eligibility, payer recognition, and compliance implications across specialty pharmacy settings.

Conference presenters highlighted gaps in menopause medication coverage and follow-up support, describing opportunities for pharmacist involvement while offering no comparative evidence that employer-sponsored programs improve symptoms, adherence, or workplace outcomes.

Updated infectious diseases guidance addresses resistant gram-negative infections through pathogen-specific treatment pathways, incorporating newer antibiotics and pharmacologic considerations while acknowledging that several preferred approaches rest on limited clinical outcomes data.

Researchers reported changes in brain functional connectivity after adding N-acetylcysteine to ongoing multiple sclerosis treatment, an early imaging signal that requires confirmation in larger studies with defined dosing and clinical outcomes.

The FDA has approved once-monthly subcutaneous olanzapine for adults with schizophrenia, supported by placebo-controlled trial data showing symptom improvement and sustained efficacy through 48 weeks, while eliminating several logistical requirements associated with treatment initiation.